Search

Search any products, services and so on here.

About 21739 result(s)

Global Acetyl-L Carnitine (ALC) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216938
  • Pages: 94
  • Figures: 92
  • Views: 40
  • From $4,250

The global Acetyl-L Carnitine (ALC) market size was US$ 55.7 million in 2024 and is forecast to a readjusted size of US$ 75.4 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031. Acetyl-L-carnitine, ALCAR or ALC, is an acetylated form of L-carnitine. It is naturally produced by the body, although it is often taken as a dietary supplement. Acetylcarnitine is broken down in the...


Global Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216942
  • Pages: 105
  • Figures: 105
  • Views: 30
  • From $4,250

The global Transdermal Patch market size was US$ 7287 million in 2024 and is forecast to a readjusted size of US$ 9302 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031. Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal...


Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216992
  • Pages: 79
  • Figures: 77
  • Views: 47
  • From $4,250

The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031. Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in...


Global Intravenous Immunoglobulin (IVIg) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216835
  • Pages: 93
  • Figures: 95
  • Views: 174
  • From $4,250

The global Intravenous Immunoglobulin (IVIg) market size was US$ 11550 million in 2024 and is forecast to a readjusted size of US$ 17160 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031. Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approxim...


Global Brucellosis Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216841
  • Pages: 104
  • Figures: 108
  • Views: 55
  • From $4,250

The global Brucellosis Vaccines market size was US$ 11.8 million in 2024 and is forecast to a readjusted size of US$ 15.2 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031. Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans. Global Brucellosis Vaccines main players are Jinyu, Colorado Se...


Global Calcium Tablets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216716
  • Pages: 78
  • Figures: 76
  • Views: 40
  • From $4,250

The global Calcium Tablets market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Calcium tablets are elemental forms of calcium, an essential mineral for human health that may be taken to supplement calcium obtained from dietary sources or to address a calcium deficiency. Most supplements contain one o...


Global Glucagon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216719
  • Pages: 80
  • Figures: 80
  • Views: 48
  • From $4,250

The global Glucagon market size was US$ 625 million in 2024 and is forecast to a readjusted size of US$ 941 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031. Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the blo...


Global Opioids Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216727
  • Pages: 97
  • Figures: 92
  • Views: 36
  • From $4,250

The global Opioids Drug market size was US$ 9694 million in 2024 and is forecast to a readjusted size of US$ 8552 million by 2031 with a CAGR of -1.8% during the forecast period 2025-2031. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®...


Global Oxyclozanide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216788
  • Pages: 99
  • Figures: 94
  • Views: 46
  • From $4,250

The global Oxyclozanide market size was US$ 33.8 million in 2024 and is forecast to a readjusted size of US$ 64.8 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031. Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxida...


Global Empagliflozin Drug Market Research Report 2025

  • May 05, 25
  • ID: 207374
  • Pages: 85
  • Figures: 83
  • Views: 39
  • From $2,900

The global market for Empagliflozin Drug was valued at US$ 19490 million in the year 2024 and is projected to reach a revised size of US$ 51550 million by 2031, growing at a CAGR of 15.7% during the forecast period. Empagliflozin is an oral antidiabetic drug that belongs to the class of SGLT2 (sodium-glucose co-transporter 2) inhibitors. It works by reducing glucose reabsorption in the kidneys, le...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232